News - Gastro-intestinals

Filter

Current filters:

Gastro-intestinals

Popular Filters

100 to 124 of 187 results

Study finds potential use of ustekinumab for Crohn's disease

18-10-2012

Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive results…

BiotechnologyGastro-intestinalsJanssenJohnson & JohnsonPharmaceuticalResearchStelara Injectionustekinumab

Unanimous FDA advisory panel backing for NPS Pharma's Gattex

17-10-2012

The US Food and Drug Administration's Gastrointestinal Drugs Advisory Committee yesterday voted unanimously…

Gastro-intestinalsGattexNorth AmericaNPS PharmaceuticalsPharmaceuticalRegulationteduglutide

FDA posts briefing papers for review of NPS Pharma's Gattex for SBS

15-10-2012

The USA Food and Drug Administration has posted briefing materials for the October 16 Gastrointestinal…

Gastro-intestinalsGattexNorth AmericaNPS PharmaceuticalsPharmaceuticalRegulation

Abbott's Humira gets FDA backing for new use

30-09-2012

US health care major Abbott Laboratories (NYSE: ABT) says that the US Food and Drug Administration has…

Abbott LaboratoriesGastro-intestinalsHumiraNorth AmericaPharmaceuticalRegulation

Uptake of biosimilars will see Remicade and Humira sales decline in 2017

26-09-2012

The TNF-alpha inhibitors infliximab (Janssen Biotech/Merck/Mitsubishi Tanabe's Remicade) and adalimumab…

BiotechnologyGastro-intestinalsGenericsGlobalHumiraMarkets & MarketingRemicade

EMA backs Almirall's Constella; Bayer's Eylea recommended by CHMP

24-09-2012

The European Medicines Agency last Friday issued a batch of recommendations relating to marketing authorization…

AlmirallBayerConstellaEuropeEyleaGastro-intestinalsIronwood PharmaceuticalsNorth AmericaOphthalmicsPharmaceuticalRegeneronRegulation

Pharmaceutical majors unite in Japan to combat H. pylori

18-09-2012

On August 31, nine pharmaceutical companies operating in Japan (Kyowa Hakko Kirin, Takeda Pharmaceutical,…

Antibiotics and Infectious diseasesAsia-PacificAstraZenecaGastro-intestinalsPharmaceuticalRegulationTakeda Pharmaceuticals

Pfizer links with SFJ Pharma for dacomitinib trial; settles with Mylan

10-09-2012

SFJ Pharmaceuticals Group, a global drug development group of companies which provides a unique co-development…

dacomitinibDetrol LAGastro-intestinalsGenericsLegalMylan LaboratoriesNorth AmericaOncologyPatentsPfizerPharmaceuticalResearchSFJ Pharmaceuticals

Almirall gains rights for IBS drug linaclotide in Mexico

10-09-2012

Spain's largest drugmaker Almirall (ALM. MC) says it has reached an agreement with USA-based Forest Laboratories…

AlmirallForest LaboratoriesGastro-intestinalsLicensinglinaclotidePharmaceuticalSouth America

US gastroenterologists' attitudes to prescribing for Crohn's disease and ulcerative colitis

09-09-2012

When evaluating the most important attributes for emerging therapies for Crohn's disease (CD) and ulcerative…

BiotechnologyGastro-intestinalsHumiraMarkets & MarketingNorth AmericaRemicadeSimponi Injectionvedolizumab

FDA action on Salix' crofelemer delayed until 2013

05-09-2012

There was disappointing news for Salix Pharmaceuticals (Nasdaq: SLXP) with the Food and Drug Administration…

crofelemerGastro-intestinalsNorth AmericaPharmaceuticalRegulationSalix Pharmaceuticals

Takeda's Revestive gets EU clearance for short bowel syndrome

05-09-2012

Japan's largest drugmaker Takeda Pharmaceutical (TSE: 4502) and partner NPS Pharmaceuticals (Nasdaq:…

EuropeGastro-intestinalsNPS PharmaceuticalsPharmaceuticalRegulationRevestiveTakeda Pharmaceuticals

FDA nod for use of Ironwood and Forest's Linzess in certain cases of IBS and constipation

03-09-2012

The US Food and Drug Administration last week approved Linzess (linaclotide), co-marketed by US drugmakers…

Forest LaboratoriesGastro-intestinalsIronwood PharmaceuticalslinaclotideLinzessNorth AmericaPharmaceuticalRegulation

Abbott's Humira cleared for Crohn's disease in EU

31-08-2012

The European Commission has approved US health care major Abbott Laboratories' (NYSE: ABT) blockbuster…

Abbott LaboratoriesAnti-Arthritics/RheumaticsBiotechnologyEuropeGastro-intestinalsHumiraPharmaceuticalRegulation

Abbott's Humira gains FDA panel backing for wider use

29-08-2012

The US Food and Drug Administration's Gastrointestinal Drugs Advisory Committee yesterday voted by 15…

Abbott LaboratoriesAnti-Arthritics/RheumaticsBiotechnologyGastro-intestinalsHumiraNorth AmericaPharmaceuticalRegulation

Pushing the IBS pipeline for promising therapies

27-08-2012

Both the current filed status and Phase III pipeline for irritable bowel syndrome (IBS) are sparse. The…

Gastro-intestinalsMarkets & MarketingPharmaceuticalResearch

ICDR rules in favor of Glenmark over Crofelemer

23-08-2012

Indian drugmaker Glenmark Pharmaceuticals saw its shares rise 2.3% to 415 rupees yesterday after the…

crofelemerGastro-intestinalsGlenmark PharmaceuticalsLegalNapo PharmaceuticalsPharmaceutical

Pfizer RA drug candidate tofacitinib shows promise in ulcerative colitis

16-08-2012

Patients with moderately to severely active ulcerative colitis treated with drug behemoth Pfizer's (NYSE…

Gastro-intestinalsPfizerPharmaceuticalResearchtofacitinib

AstraZeneca to get $250 million-plus from OTC Nexium deal with Pfizer

15-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says it has entered into an agreement with Pfizer (NYSE:…

AstraZenecaFinancialGastro-intestinalsGlobalLicensingNexiumPfizerPharmaceutical

Salix and Alfa Wassermann expand rifaximin accord

10-08-2012

USA-based Salix Pharmaceuticals (Nasdaq: SLXP) and Italy's Alfa Wassermann have entered into an exclusive…

Alfa WassermannGastro-intestinalsLicensingPharmaceuticalRespiratory and PulmonaryrifaximinSalix Pharmaceuticals

Latest role for aspirin may be in protecting against Barrett's esophagus

24-07-2012

Along with its original use as a pain killer, and its protection against heart attack, the ubiquitous…

AspirinGastro-intestinalsPharmaceuticalResearch

100 to 124 of 187 results

Company Spotlight

Fibrotech

Fibrotech

Back to top